Senner Christopher J.

CIK 00016483672 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001648367

Recent Transactions

50 trades

Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2026-01-15$45.23/sh−40,459→ 1,076,857 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2026-01-15+149,474→ 1,117,316 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (Right to Buy)
2026-01-02+21,810→ 21,810 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (Right to Buy)
2025-06-04+27,000→ 27,000 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-05-16$18.80/sh+100,000→ 1,067,842 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-05-16$46.00/sh−100,000→ 967,842 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-05-16−100,000→ 0 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2025-05-15$44.65/sh−41,422→ 967,842 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-03-31+170,009→ 1,009,264 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-02-26+59,648→ 839,255 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-02-24$18.80/sh+29,314→ 808,921 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-02-24−29,314→ 100,000 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-02-24$36.14/sh−29,314→ 779,607 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2025-02-15$35.00/sh−21,591→ 779,607 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2025-01-16$37.27/sh−35,949→ 801,198 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-01-16+132,973→ 837,147 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (right to buy)
2025-01-02+35,274→ 35,274 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2024-11-15$35.05/sh−17,506→ 704,174 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2024-08-09−125,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2024-08-09$27.19/sh−125,000→ 721,680 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2024-08-09$24.41/sh+125,000→ 846,680 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2024-06-05+27,000→ 27,000 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2024-05-15$20.99/sh−11,478→ 721,680 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2024-05-15$20.99/sh−10,211→ 733,158 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2024-05-15$20.99/sh−8,621→ 743,369 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-02-23+82,121→ 751,990 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-01-11+80,186→ 691,731 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2024-01-11$22.86/sh−21,862→ 669,869 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2023-09-06+65,135→ 628,692 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2023-09-06$22.27/sh−17,147→ 611,545 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2023-08-15$21.51/sh−8,074→ 563,557 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-08-04−60,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2023-08-04$20.68/sh−60,000→ 571,631 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2023-08-04$14.74/sh+60,000→ 631,631 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-08-03−60,000→ 60,000 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2023-08-03$20.51/sh−60,000→ 571,631 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2023-08-03$14.74/sh+60,000→ 631,631 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2023-05-24+27,000→ 27,000 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2023-05-15$19.18/sh−8,444→ 581,633 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2023-05-15$19.18/sh−10,002→ 571,631 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2023-04-03+85,414→ 590,077 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2023-02-15$18.08/sh−5,278→ 504,663 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2022-11-15$16.71/sh−8,074→ 509,941 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2022-08-11$6.21/sh+225,000→ 670,882 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2022-08-11−225,000→ 0 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2022-08-11$19.23/sh−152,867→ 518,015 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2022-08-03+32,567→ 453,956 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2022-08-03$21.49/sh−8,074→ 445,882 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2022-06-08+27,000→ 27,000 total
Tax Payment
EXELIXIS, INC.$EXEL
Common Stock
2022-05-15$20.08/sh−8,444→ 421,389 total

Companies

Recent Filings

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov